SABS (SAB Biotherapeutics) Pangali Forward P/E
SAB Biotherapeutics (SABS) is currently undergoing the clinical validation stage of an innovative method for combating type 1 diabetes. The trend of the company's forward P/E ratio clearly demonstrates market expectations, where the 0.00 level indicates the status of the parameter. The business is creating a defensive barrier by utilizing polyclonal antibodies from transgenic livestock. The DiversitAb platform enables the rapid production of proteins against cancer and viruses, ensuring strategic security.
Rincian analitis perusahaan SAB Biotherapeutics
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas SAB Biotherapeutics|SABS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas SAB Biotherapeutics|SABS - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku SAB Biotherapeutics Inc.|SABS - Utang jangka dawa|Utang jangka cendhak perusahaan SAB Biotherapeutics|Rasio cepet sabbiotherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
SABS - Bathi resik|Proyeksi bathi mangsa ngarep SAB Biotherapeutics|SABS - Rasio rega marang bathi|Prakiraan rega marang bathi SAB Biotherapeutics, Inc|SABS - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA SAB Biotherapeutics Inc.|SABS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) SAB Biotherapeutics|SABS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sabbiotherapeutics.com|SABS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep SAB Biotherapeutics
Ringkesan analitik perusahaan:SAB Biotherapeutics, Inc.
High development costs for the antibody platform and SAB Biotherapeutics (SABS) dependence on external capital make profit forecasts a critical valuation factor. By analyzing the company's expected P/E valuation, an investor determines the cost of one dollar of future net income, which allows for the identification of asset overheating or hidden risks that directly impact long-term capital sustainability.
Pesaing SAB Biotherapeutics (SABS)
Prakiraan rega marang bathi ARGX (argenx)|BNTX (BioNTech Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (abivax.com)|Kapitalisasi marang proyeksi bathi ADMA Corp (ADMA)|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|Kiniksa (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols SA|Prakiraan rega marang bathi ADPT|Pangali Forward P/E Celldex Corp|Rega marang bathi mangsa ngarep Aurinia Pharmaceuticals (AUPH)|biocryst.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi AbCellera Biologics ABCL|TRML: Pangali Forward P/E|precigen.com (PGEN) - Pangali Forward P/E|PHAR (Pharming Group) - Pangali Forward P/E|Rega marang bathi mangsa ngarep NKTR|Prakiraan rega marang bathi UPB (Upstream Bio Corp)|ZBIO (Zenas Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E IMNM (Immunome, Inc.)|gossamerbio.com - Rega marang bathi mangsa ngarep|KalVista Pharmaceuticals, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Savara Pharma (SVRA)|Prakiraan rega marang bathi RIGL|ANAB (anaptysbio.com) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ATXS|ENGN (enGene Holdings Inc) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - Rasio prakiraan rega marang bathi|ACRS - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi KYTX (kyvernatx.com)|TLSA: Pangali Forward P/E|Cabaletta Bio Inc. (CABA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Ventyx Bio|Theratechnologies, Inc - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E AVTX|ELDN - Rasio prakiraan rega marang bathi|Agenus Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Climb Bio Inc. CLYM|ZURA: Prakiraan rega marang bathi|aTyr Pharmaceuticals - Rasio kapitalisasi marang bathi mangsa ngarep|ADAG: Pangali Forward P/E|IMA - Kapitalisasi marang proyeksi bathi|STTK (Shattuck Labs Inc) - Pangali Forward P/E|Prakiraan rega marang bathi Equillium Bio (EQ)|Rega marang bathi mangsa ngarep Connect Biopharma (CNTB)|Kapitalisasi marang proyeksi bathi immunic-therapeutics.com|Rega marang bathi mangsa ngarep Atara Bio ATRA|Kapitalisasi marang proyeksi bathi InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. - Pangali Forward P/E|ACET - Pangali Forward P/E|CELU: Pangali Forward P/E|INMB (INmune Bio Corporation) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Barinthus Biotherapeutics|kezarlifesciences.com (KZR) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Akari Therapeutics Plc (AKTX)|ENLV: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E QTTB (Q32 Bio)|Pangali mangsa ngarep rega marang bathi GOVX|Edesa Biotech, Inc. - Pangali Forward P/E|IBIO - Pangali Forward P/E|carismatx.com (CARM) - Rega marang bathi mangsa ngarep|XTL Biopharmaceuticals Ltd - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Bolt Biotherapeutics Inc.|Prakiraan rega marang bathi HCW Biologics Inc (HCWB)|Pangali Forward P/E APVO|Pangali Forward P/E AIM ImmunoTech, Inc. (AIM)|Aditxt, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi GRI|XORTX - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi indaptusrx.com|Rega marang bathi mangsa ngarep Scinai Immunotherapeutics Ltd.|Prakiraan rega marang bathi CalciMedica Corp (CALI)|Prakiraan rega marang bathi AFMD (Affimed)|Pangali Forward P/E allakos.com (ALLK)|Rega marang bathi mangsa ngarep HOOKIPA Pharma HOOK|IGMS: Rasio rega marang bathi mangsa ngarep|iTeos Therapeutics, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi Ocean Biomedical Inc|TC BioPharm (Holdings) PLC (TCBP) - Rega marang bathi mangsa ngarep|THRD - Kapitalisasi marang proyeksi bathi
